Aveanna Healthcare (AVAH)
Market Price (12/18/2025): $8.93 | Market Cap: $1.9 BilSector: Health Care | Industry: Health Care Facilities
Aveanna Healthcare (AVAH)
Market Price (12/18/2025): $8.93Market Cap: $1.9 BilSector: Health CareIndustry: Health Care Facilities
Investment Highlights
Why It Matters
Which of these 2 stories sounds closer for this stock?
1. Generates cash flow
The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.
2. Riding a trend
Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Chronic Disease Management, Show more. | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 65% |
| Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 61% | |
| Key risksAVAH key risks include [1] margin pressure on its core Private Duty Services segment from persistent labor shortages and wage inflation and [2] significant interest rate exposure due to its substantial variable-rate debt. |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Chronic Disease Management, Show more. |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 65% |
| Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 61% |
| Key risksAVAH key risks include [1] margin pressure on its core Private Duty Services segment from persistent labor shortages and wage inflation and [2] significant interest rate exposure due to its substantial variable-rate debt. |
Valuation, Metrics & Events
AVAH Stock
Why The Stock Moved
Qualitative Assessment
AI Generated Analysis | Feedback
I am unable to provide information regarding stock movements and their explanations for a future time period. The requested period of August 31, 2025, to December 18, 2025, is in the future, and I do not have access to future market data or events.
Show moreStock Movement Drivers
Return vs. Risk
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| AVAH Return | � | � | -89% | 244% | 71% | 93% | � |
| Peers Return | � | � | � | � | � | 37% | � |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 14% | 108% |
Monthly Win Rates [3] | |||||||
| AVAH Win Rate | � | 25% | 17% | 50% | 58% | 58% | |
| Peers Win Rate | � | � | � | � | 60% | 62% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 73% | |
Max Drawdowns [4] | |||||||
| AVAH Max Drawdown | � | � | -91% | -9% | -19% | -19% | |
| Peers Max Drawdown | � | � | � | � | � | -11% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: ADUS, EHAB, EHC, OPCH, BTSG.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/17/2025 (YTD)
How Low Can It Go
| Event | AVAH | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -94.8% | -25.4% |
| % Gain to Breakeven | 1807.9% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
Compare to ACHC, AMTU, AVG, MCTA, SRTA
In The Past
Aveanna Healthcare's stock fell -94.8% during the 2022 Inflation Shock from a high on 6/14/2021. A -94.8% loss requires a 1807.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Latest Trefis Analyses
Trade Ideas
Select past ideas related to AVAH. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11142025 | CRL | Charles River Laboratories International | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 16.3% | 16.3% | -3.7% |
| 11142025 | GDRX | GoodRx | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | -7.1% | -7.1% | -11.8% |
| 11142025 | ASTH | Astrana Health | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 3.6% | 3.6% | -5.5% |
| 11142025 | SGRY | Surgery Partners | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 1.6% | 1.6% | -1.4% |
| 11072025 | TFX | Teleflex | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 14.1% | 14.1% | -5.1% |
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11142025 | CRL | Charles River Laboratories International | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 16.3% | 16.3% | -3.7% |
| 11142025 | GDRX | GoodRx | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | -7.1% | -7.1% | -11.8% |
| 11142025 | ASTH | Astrana Health | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 3.6% | 3.6% | -5.5% |
| 11142025 | SGRY | Surgery Partners | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 1.6% | 1.6% | -1.4% |
| 11072025 | TFX | Teleflex | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 14.1% | 14.1% | -5.1% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Aveanna Healthcare
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 34.27 |
| Mkt Cap | 3.7 |
| Rev LTM | 3,911 |
| Op Inc LTM | 284 |
| FCF LTM | 159 |
| FCF 3Y Avg | 81 |
| CFO LTM | 181 |
| CFO 3Y Avg | 124 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 15.6% |
| Rev Chg 3Y Avg | 11.9% |
| Rev Chg Q | 17.2% |
| QoQ Delta Rev Chg LTM | 4.0% |
| Op Mgn LTM | 7.6% |
| Op Mgn 3Y Avg | 6.8% |
| QoQ Delta Op Mgn LTM | 0.3% |
| CFO/Rev LTM | 5.3% |
| CFO/Rev 3Y Avg | 6.1% |
| FCF/Rev LTM | 4.8% |
| FCF/Rev 3Y Avg | 5.4% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 3.7 |
| P/S | 0.8 |
| P/EBIT | 14.1 |
| P/E | 24.1 |
| P/CFO | 17.3 |
| Total Yield | 4.0% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | 5.3% |
| D/E | 0.4 |
| Net D/E | 0.3 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 9.1% |
| 3M Rtn | 14.1% |
| 6M Rtn | 3.7% |
| 12M Rtn | 28.4% |
| 3Y Rtn | 10.6% |
| 1M Excs Rtn | 8.4% |
| 3M Excs Rtn | 9.5% |
| 6M Excs Rtn | -8.6% |
| 12M Excs Rtn | 15.6% |
| 3Y Excs Rtn | -59.7% |
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 10/21/2025 | -7.4% | -4.1% | -17.4% |
| 8/7/2025 | 49.4% | 83.8% | 111.3% |
| 3/13/2025 | 37.4% | 47.3% | 28.3% |
| 11/7/2024 | 16.2% | 19.3% | 11.4% |
| 8/8/2024 | 32.2% | 33.5% | 58.0% |
| 3/14/2024 | -3.0% | -2.4% | -6.4% |
| 11/9/2023 | 2.0% | 27.9% | 75.8% |
| 3/16/2023 | -6.7% | -33.2% | -16.1% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 7 | 6 | 6 |
| # Negative | 7 | 8 | 8 |
| Median Positive | 16.2% | 30.7% | 43.2% |
| Median Negative | -7.6% | -17.8% | -17.5% |
| Max Positive | 49.4% | 83.8% | 111.3% |
| Max Negative | -26.7% | -38.0% | -44.0% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 11062025 | 10-Q 9/27/2025 |
| 6302025 | 8072025 | 10-Q 6/28/2025 |
| 3312025 | 5082025 | 10-Q 3/29/2025 |
| 12312024 | 3132025 | 10-K 12/28/2024 |
| 9302024 | 11072024 | 10-Q 9/28/2024 |
| 6302024 | 8082024 | 10-Q 6/29/2024 |
| 3312024 | 5092024 | 10-Q 3/30/2024 |
| 12312023 | 3142024 | 10-K 12/30/2023 |
| 9302023 | 11092023 | 10-Q 9/30/2023 |
| 6302023 | 8102023 | 10-Q 7/1/2023 |
| 3312023 | 5112023 | 10-Q 4/1/2023 |
| 12312022 | 3162023 | 10-K 12/31/2022 |
| 9302022 | 11152022 | 10-Q 10/1/2022 |
| 6302022 | 8112022 | 10-Q 7/2/2022 |
| 3312022 | 5112022 | 10-Q 4/2/2022 |
| 12312021 | 3282022 | 10-K 1/1/2022 |
Insider Activity
Expand for More| Owner | Title | Filing Date | Action | Price | Shares | TransactedValue | Value ofHeld Shares | Form | |
|---|---|---|---|---|---|---|---|---|---|
| 0 | VIGANO PAUL R | 10282025 | Sell | 9.00 | 1,251,909 | 11,267,181 | 173,635,083 | Form | |
| 1 | J.H. Whitney Equity Partners VII, LLC | 10282025 | Sell | 9.00 | 1,251,909 | 11,267,181 | 173,635,083 | Form | |
| 2 | WILLIAMS ROBERT M JR | 10282025 | Sell | 9.00 | 1,251,909 | 11,267,181 | 173,635,083 | Form | |
| 3 | WILLIAMS ROBERT M JR | 10232025 | Sell | 9.00 | 8,346,059 | 75,114,531 | 184,902,264 | Form | |
| 4 | VIGANO PAUL R | 10232025 | Sell | 9.00 | 8,346,059 | 75,114,531 | 184,902,264 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |